Rong Chen
Technik-/Wissenschafts-/F&E-Leiter bei JHL BIOTECH, INC.
Profil
Rong Chen is currently the Chief Medical Officer at Eden Biologics, Inc. He previously worked as the Chief Medical Officer at CASI Pharmaceuticals,.
Inc. Chen received a doctorate degree from the University of Adelaide in 1989 and an undergraduate degree from Shandong Medical University.
Aktive Positionen von Rong Chen
Unternehmen | Position | Beginn |
---|---|---|
JHL BIOTECH, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2018 |
Ehemalige bekannte Positionen von Rong Chen
Unternehmen | Position | Ende |
---|---|---|
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Rong Chen
Shandong Medical University | Undergraduate Degree |
University of Adelaide | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | Health Technology |
Eden Biologics, Inc.
Eden Biologics, Inc. Pharmaceuticals: MajorHealth Technology Eden Biologics, Inc. is engaged in the manufacture and sale of bio-pharmaceuticals products. It offers cell line cloning, antibody cloning, monoclonal antibody, cell line development, master and working cell banks, cell culture process development, purification process development, formulation development, and analytical assays. The company was founded on June 14, 2012 and is headquartered in Zhupei, Taiwan. | Health Technology |